Resveratrol sensitizes androgen independent prostate cancer cells to death‐receptor mediated apoptosis through multiple mechanisms

Abstract

Altering apoptotic susceptibility in advanced androgen independent disease requires manipulation of a broad signaling pathway. Use of resveratrol or inhibition of Akt phosphorylation may represent an important therapeutic approach in combination with conventional therapies for the treatment of prostate cancer.